MDAngle
Article

Myasthenia Gravis: Lessons on a Comprehensive Approach to Patient Care

Nicholas J. Silvestri, MD, Associate Professor, Department of Neurology, University at Buffalo Jacobs School of Medicine & Biomedical Sciences; Staff Physician, UBMD, Buffalo, New York

Nicholas J. Silvestri, MD, has disclosed the following relevant financial relationships:

Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Argenx; Alexion; Immunovant; UCB

Serve(d) as a speaker or a member of a speakers bureau for: Argenx; Alexion; UCB


 

Nicholas J. Silvestri, MD, expresses gratitude for the impactful relationships and mentorship in the field of myasthenia gravis. Dr Chip Howard at the University of North Carolina is distinguished as a humble and inclusive mentor, considered influential in the field.

Dr Howard's influence goes beyond the efficacy of medications, emphasizing the importance of considering patient care comprehensively, including side effects and overall safety. This perspective has significantly shaped Dr Silvestri’s treatment approach, leading to a more holistic and patient-centered care paradigm for individuals with myasthenia gravis.

Recommended Reading

Evolving Treatment Options for Generalized Myasthenia Gravis
MDedge Neurology
Myasthenia gravis: Finding strength in treatment options
MDedge Neurology
U.S. incidence, prevalence of myasthenia gravis is rising
MDedge Neurology
Clinical Advances in Myasthenia Gravis From AAN 2023
MDedge Neurology
Myasthenia gravis drug gets FDA nod
MDedge Neurology
In myasthenia gravis, antibodies pass open-label tests
MDedge Neurology
U.S. study finds unexpectedly high prevalence of myasthenia gravis
MDedge Neurology
Newly approved myasthenia gravis drug shows sustained benefits in early responders
MDedge Neurology
Novel myasthenia gravis therapies bring opportunities, challenges
MDedge Neurology
Autoimmune Disease Risk May Rise Following Cushing Disease Remission After Surgery
MDedge Neurology